ALung brings in $12M to move forward with approval of its artificial lung
ALung Technologies Inc. has secured $12 million from investors. The Pittsburgh-based medical device company is working toward U.S. regulatory approval of its artificial lung.
ALung secures $10M ahead of artifical lung system’s launch in Germany
ALung Technologies Inc. has raised a $10 million series B round in preparation for a product launch of its Hemolung oxygen-delivery device in Germany this year, the Pittsburgh Tribune-Review is reporting. MedCity News reported back in December that the medical device company had already raised $6.6 million and filed for the CE Mark. The Hemolung […]
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
ALung planning European launch of artificial lung system
ALung Technologies is targeting a $10 million series B round of investment for the European launch of its respiratory assistance system that removes carbon dioxide from a patient’s blood while directly infusing the blood with oxygen. The company is already most of the way there, having just closed on $6.6 million and having received commitments […]
Pittsburgh’s ALung raises $14M for artificial lung system
More than 100 angel investors helped ALung Technologies Inc. in Pittsburgh, Pennsylvania, to a $14 million fundraising round, according to Pop City. ALung will use the latest investor capital to pay for ongoing clinical trials of its Hemolung Respiratory Assist System -- a kind of artificial lung that removes carbon dioxide directly from a patient's blood while infusing it with oxygen.
ALung Technologies adds $2.8M in equity to anticipated $10M round
Respiratory-assistance company ALung Technologies Inc. has added $2.8 million in equity to what it hopes will be a $10 million round of investment funding, according to a Securities and Exchange Commission filing. The latest fundraise brings to $6.1 million the amount that ALung has raised since February. The funding includes contributions from 22 investors, according […]
Pittsburgh’s ALung grabs $3.3M for artificial breathing system
ALung Technologies Inc. has raised $3.3 million in equity as part of an intended $10 million offering. The company is developing a respiratory-assistance system it calls the Hemolung, which delivers oxygen directly into the blood using a catheter into the femoral or jugular vein.
presented by
3D Medical Animation Services: A Revolution in Healthcare Education and Marketing
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
Pittsburgh’s ALung raises $2.5 million for clinical trials
The company is developing its Hemolung System, which delivers oxygen directly into the blood using a catheter into the jugular vein. Later this year it will start a five-patient human trial in India and a 20-patient trial in Germany.